Targeted imaging of esophageal adenocarcinoma with a near-infrared fluorescent peptide.
Targeted imaging of esophageal adenocarcinoma with a near-infrared fluorescent peptide.
复制标题
DOI:
10.1186/s12876-021-01840-3
复制
发表时间:
2021-06-12
影响因子:
2.4
通讯作者:
Wu K
中科院分区:
文献类型:
--
作者:
Kang X;Li M;Liu L;Liu S;Hu H;Zhang R;Ning S;Tian Z;Pan Y;Guo X;Wu K
Targeted optical imaging offers a noninvasive and accurate method for the early detection of gastrointestinal tumors, especially for flat appearances. In our previous study, a sequence of SNFYMPL (SNF) was identified as a specific peptide to bind to esophageal carcinoma using phage-display technology. This study aimed to evaluate the tumor-targeting efficacy of Cy5.5-conjugated SNF probe for imaging of esophageal carcinoma in vitro and in vivo. The SNF-Cy5.5 probe was synthesized and then identified using High Performance Liquid Chromatography (HPLC) and mass spectrometry (MS). Confocal fluorescence imaging and Flow cytometry analysis were performed to evaluate the binding specificity and the receptor binding affinity of SNF-Cy5.5 to OE33. In vivo imaging was performed to evaluate the targeting ability of SNF-Cy5.5 to esophageal carcinoma. The confocal imaging and flow cytometry analysis showed that SNF-Cy5.5 bound specifically to the plasma membrane of OE33 cells with a high affinity. In vivo, for non-block group, SNF-Cy5.5 probe exhibited rapid OE33 tumor targeting during 24 h p.i. and excellent tumor-to-background contrast at 2 h p.i. For the block group, SNF-Cy5.5 was not observed in the mice after 4 h p.i. Ex vivo imaging also revealed that a higher fluorescent signal intensity value of the tumors was clearly observed in the non-block group than that in the block group (2.6 ± 0.32 × 109 vs. 0.8 ± 0.08 × 109, p < 0.05). SNF-Cy5.5 was synthesized and characterized with a high efficiency and purity. The higher affinity, specificity, and tumor targeting efficacy of SNF-Cy5.5 were confirmed by in vitro and in vivo tests. SNF-Cy5.5 is a promising optical probe for the imaging of esophageal adenocarcinoma. The online version contains supplementary material available at 10.1186/s12876-021-01840-3.
登录
查看更多内容
影响因子:
5.8
作者:
Feng, Shuo;Zhou, Juan;Wang, Thomas D.
通讯作者:
Wang, Thomas D.
影响因子:
7.3
作者:
Chen J;Zhou J;Gao Z;Li X;Wang F;Duan X;Li G;Joshi BP;Kuick R;Appelman HD;Wang TD
通讯作者:
Wang TD
影响因子:
2.8
作者:
Ding S;Blue RE;Moorefield E;Yuan H;Lund PK
通讯作者:
Lund PK
影响因子:
29.4
作者:
Li M;Anastassiades CP;Joshi B;Komarck CM;Piraka C;Elmunzer BJ;Turgeon DK;Johnson TD;Appelman H;Beer DG;Wang TD
通讯作者:
Wang TD
DOI:
10.1007/s00259-011-1886-x
发表时间:
2011-11
影响因子:
9.1
作者:
Yang, Yunan;Zhang, Yin;Hong, Hao;Liu, Glenn;Leigh, Bryan R.;Cai, Weibo
通讯作者:
Cai, Weibo